PepGen PEPG
NASDAQ PEPG
$3.11 -0.07 (-2.20%)
As of: Sep 4, 2026 · 3:59 PM EDT

PepGen (PEPG) Cash from Restructuring (2022 - 2025)

PepGen (PEPG) posted Cash from Restructuring of -$11000.0 for Q2 2025, down 200.0% sequentially from $11000.0 in Q1 2025.

Analysis

PepGen (PEPG) Cash from Restructuring (2022 - 2025) Analysis & Trends

PepGen has reported Cash from Restructuring for 3 years, with the latest figure at -$11000.0 in Q2 2025.

  • Quarterly Cash from Restructuring changed N/A year-over-year to -$11000.0 in Q2 2025, while the trailing twelve-month figure through Sep 2025 was $50000.0 (up 177.78% YoY) and the FY2024 annual result came in at $70000.0, changed N/A from the prior year.
  • Cash from Restructuring fell to -$11000.0 in Q2 2025 per PEPG's latest filing, from $11000.0 in the prior quarter.
  • Over five years, Cash from Restructuring peaked at $50000.0 in Q4 2024 and troughed at -$11000.0 in Q2 2025.
  • A 3-year average of $13600.0 and a median of $11000.0 in 2025 frame the typical range for Cash from Restructuring.
  • The widest YoY moves for Cash from Restructuring: up 45.0% in 2025, down 45.0% in 2025.
  • Over 3 years, Cash from Restructuring stood at -$2000.0 in 2022, then surged by 2600.0% to $50000.0 in 2024, then sank by 122.0% to -$11000.0 in 2025.
  • According to Business Quant data, Cash from Restructuring over the past three periods registered -$11000.0, $11000.0, and $50000.0 for Q2 2025, Q1 2025, and Q4 2024 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 PepGen 217.99 Mn 217.99 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 -11,000.00
Mar 31, 2025 11,000.00
Dec 31, 2024 50,000.00
Mar 31, 2024 20,000.00
Dec 31, 2022 -2,000.00